Altimmune, Inc. · LSX:A2N5Z6

Altimmune, Inc. financial statements

Altimmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue41.0K20.0K426.0K-68.0K4.41M8.19M5.80M10.3M10.7M3.24M
Cost of revenue112.0K238.0K477.0K500.0K73.8M33.5M17.1M18.5M18.4M7.22M
Gross profit41.0K20.0K426.0K-68.0K4.41M-25.3M5.80M-8.13M-18.4M-1.99M
Research and development66.4M82.2M65.8M70.5M74.5M49.8M17.8M18.5M18.4M7.22M
Selling, general and administrative28.1M21.0M18.1M17.1M15.4M13.2M8.50M9.77M8.46M11.5M
Operating income-94.5M-103.2M-95.9M-87.7M-96.9M-54.8M-21.5M-42.8M-52.0M-11.1M
Depreciation and amortization112.0K238.0K477.0K-205.0K551.3K428.9K387.3K218.7K83.8K63.1K
EBITDA-94.4M-102.9M-95.5M-87.9M-96.4M-54.4M-21.1M-42.6M-52.0M-11.0M
Interest expense1.64M9.00K35.0K8.00K5.00K9.42K2.24K297.1K162.1K38.5K
Income before tax-88.8M-95.1M-88.4M-84.9M-97.1M-54.5M-20.6M-45.3M-52.1M-11.1M
Income tax-681.0K309.1K-197.0K-919.5K-5.42M-58.5K-6.15M-5.64M0
Net income-88.1M-95.1M-88.4M-84.7M-97.1M-49.0M-20.5M-39.2M-46.4M-11.1M
Earnings per share, basic-1.00-1.34-1.66-1.81-2.35-1.91-1.60-15.16-118.912.97
Earnings per share, diluted-1.00-1.34-1.66-1.81-2.35-1.91-1.60-15.16-118.912.95

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents43.8M36.9M135.1M111.1M190.3M115.9M8.96M33.7M8.77M2.88M
Short-term investments229.7M95.0M62.7M73.8M0100.0M28.3M3.53M66.8M
Receivables1.74M3.12M4.85M2.54M5.84M12.4M1.65M4.47M10.2M999.1K
Inventory34.0K-13.4B-1.96B-503.9M3.53M0
Current assets278.2M137.3M209.6M192.8M204.1M230.3M39.4M39.4M23.5M4.49M
Property, plant and equipment312.0K413.0K651.0K1.08M1.45M1.06M1.10M1.34M603.1K177.9K
Goodwill00018.8M
Total assets279.9M139.3M210.6M206.9M218.9M245.1M54.1M54.8M63.0M38.4M
Accounts payable2.72M211.0K2.07M4.80M2.03M612.3K18.2K372.9K129.1K2.01M
Current liabilities15.0M10.5M12.1M17.1M18.3M12.0M3.92M4.53M3.84M5.47M
Long-term debt34.3M4.58M1.45M1.83M1.86M1.85M4.57M526.0K
Total debt34.3M1.68M671.0K4.58M1.45M1.83M1.86M572.8K599.9K526.0K
Total liabilities55.0M15.8M16.5M21.6M19.7M19.2M8.54M6.44M14.4M6.19M
Shareholders' equity224.9M123.5M194.1M185.3M199.1M225.9M45.5M48.3M39.4M32.2M
Shares outstanding110.9M72.4M70.7M49.2M41.0M37.1M15.3M9.08M608.5K6.92M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-67.5M-79.8M-75.8M-62.6M-78.2M-34.3M-9.60M-9.39M-20.2M-6.35M
Capital spending-11.0K0-47.0K-126.0K-12.1M-204.0K-1.23K-975.4K-112.4K-125.0K
Free cash flow-67.5M-79.8M-75.9M-62.7M-90.4M-34.5M-9.60M-10.4M-20.3M-6.48M
Cash from investing-132.5M-28.4M13.7M-73.4M87.5M-72.2M-28.3M-1.00M13.7M-220.6K
Cash from financing206.8M10.0M86.1M56.8M65.1M213.5M12.5M32.5M15.8M4.98M
Dividends paid-135.5M-3.79B-22.9K00
Share buybacks291.0K300.0K215.0K-516.0K224.5M135.5M3.79B-2.39M13.0M3.80M
Change in cash6.83M-98.2M24.0M-79.2M74.4M107.0M-25.4M22.0M9.43M138.4M